Accelerated MDM2 auto-degradation induced by DNA-damage kinases is required for p53 activation

Jayne M Stommel1, Geoffrey M Wahl

  • 1Department of Biology, University of California, San Diego, CA, USA.

The EMBO Journal
|March 19, 2004
PubMed

Insights

The E3 ubiquitin ligase MDM2 targets p53 for degradation. DNA damage destabilizes MDM2, allowing p53 activation, revealing a new regulatory step in the p53 pathway.

Area of Science:

  • Molecular Biology
  • Cellular Biology
  • Cancer Research

Background:

  • The p53 protein is a tumor suppressor that halts the proliferation of genetically unstable cells.
  • The E3 ubiquitin ligase MDM2 antagonizes p53, promoting the viability of unstressed cells.
  • MDM2 induces p53 degradation in both nuclear and cytoplasmic compartments.

Purpose of the Study:

  • To investigate the mechanisms of p53 activation during DNA damage response despite high MDM2 levels.
  • To elucidate the role of MDM2 stability in regulating p53 activity post-DNA damage.

Main Methods:

  • Demonstration of MDM2-induced p53 degradation in nucleus and cytoplasm.
  • Investigation of p53 and MDM2 dynamics in stressed cells.
  • Analysis of MDM2 destabilization mechanisms involving damage-activated kinases and auto-ubiquitination.
  • Assessment of p53 stability and transcriptional activity correlated with MDM2 stability.
  • Experimental blocking of MDM2 destabilization in DNA-damaged cells.

Main Results:

  • DNA damage was shown to destabilize MDM2 through a process involving activated kinases and auto-ubiquitination.
  • p53 remained stable and transcriptionally active when MDM2 was unstable.
  • p53 became unstable and inactive as the DNA damage response subsided and MDM2 stabilized.
  • Inhibition of MDM2 destabilization in DNA-damaged cells abrogated p53 target gene activation.

Conclusions:

  • Controlled degradation of MDM2 is a critical regulatory mechanism for p53.
  • This finding introduces a new step in the regulation of the p53 pathway, crucial for cellular response to DNA damage.

Related Concept Videos

DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...